Nonspecific effect of Mycograb on amphotericin B MIC - sprookjes - yvandenbroek - TriplyDB

Nonspecific effect of Mycograb on amphotericin B MIC

Nonspecific effect of Mycograb on amphotericin B MIC

http://www.wikidata.org/entity/Q24632922

about

Emerging drugs and vaccines for candidemia Human monoclonal antibody-based therapy in the treatment of invasive candidiasis Candida infections and their prevention.Antimicrobial Activity and Resistance: Influencing Factors.Immune modulators as adjuncts for the prevention and treatment of invasive fungal infections.Heat shock protein 90 (Hsp90): A novel antifungal target against Aspergillus fumigatus.The protective role of immunoglobulins in fungal infections and inflammation.Candida albicans Heat Shock Proteins and Hsps-Associated Signaling Pathways as Potential Antifungal Targets.The Elusive Anti-Candida Vaccine: Lessons From the Past and Opportunities for the Future.

P2860

Q26828993-471C0DB6-1104-428D-9E7B-404C0679014D Q26864291-68A6BA42-43AF-4A16-9568-0D715B48DE1F Q33775256-B44353FA-446D-4C94-83F4-0E3281A13344 Q33790192-A7770643-C3D8-4635-93B0-E94B0780FE22 Q38067451-9A6A0A2C-16E4-4D61-A982-BC886B460257 Q38253077-A0ABDED6-8489-4F6B-AC1A-DA043C6E16B1 Q38268922-FC1B882E-9B45-4AC6-A5A8-BF3D2A483838 Q47220163-0331214D-83FA-49FF-BD3F-8C8B934856E8 Q53683158-0B3F9366-9400-45DF-9929-0ED3B710B775

P2860

Nonspecific effect of Mycograb on amphotericin B MIC

http://www.wikidata.org/entity/Q24632922

description

2012 nî lūn-bûn

@nan

2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Nonspecific effect of Mycograb on amphotericin B MIC

@ast

Nonspecific effect of Mycograb on amphotericin B MIC

@en

Nonspecific effect of Mycograb on amphotericin B MIC

@nl

type

label

Nonspecific effect of Mycograb on amphotericin B MIC

@ast

Nonspecific effect of Mycograb on amphotericin B MIC

@en

Nonspecific effect of Mycograb on amphotericin B MIC

@nl

prefLabel

Nonspecific effect of Mycograb on amphotericin B MIC

@ast

Nonspecific effect of Mycograb on amphotericin B MIC

@en

Nonspecific effect of Mycograb on amphotericin B MIC

@nl

P1433

Q24632922-6D06DCE1-BAC4-4585-B806-681B827B8FF4

P1476

Q24632922-B714C735-F6F4-4A88-AD68-9686FFA69AB8

P2093

Q24632922-0D9C8B83-876E-4F37-83AF-4830F24AD4A4

Q24632922-464A5A55-F5E5-4F3F-9973-2FAF3D94B83B

Q24632922-63311B45-A184-488A-BC51-0F7BEBF927FA

Q24632922-81232B45-8EA2-4183-A60D-F3C5A3B11B25

Q24632922-E071EB00-4571-4980-8E4C-DEA75E314AD7

P2860

Q24632922-1868D2F1-B30B-4F6C-9657-2E56689AC357

Q24632922-8044FE36-E450-43E7-BAA3-7D47EDB14E91

Q24632922-8206D841-1D4E-4BF0-8F4E-A28D5442C08A

Q24632922-91D88904-5DF0-4E0A-AC6C-DB8297D49D4D

Q24632922-9283959E-575A-4696-B555-6CFFBC483BAE

Q24632922-9B58A520-26D8-46A1-A6AE-1B3B635318FD

Q24632922-B2F51D93-31A3-45B0-9D03-4082729D880D

P304

Q24632922-2117C112-B33C-46AB-88D1-172F5B6CAD33

P31

Q24632922-E77AF0C5-E174-4C01-BA14-F9A62F50C83F

P356

Q24632922-2634BFD1-7B46-4D7E-B1DE-478D0772B1C1

P407

Q24632922-4F5B516D-B7F7-4EE1-99FF-CF60565C43FF

P433

Q24632922-373BB355-8513-4328-BE7E-B4C2F84D2757

P478

Q24632922-5ED87732-F2FB-4FAF-AAA5-3E288E34AE67

P577

Q24632922-7E6BA9E5-3B71-416B-810D-3508E29D2CFB

P698

Q24632922-02FD6AA1-F9D0-43A9-AABB-32BEAD9851E6

P921

Q24632922-40B867DF-935C-445F-83AD-F4BB219EC097

P932

Q24632922-D7629ABA-2C92-491C-B4A1-01D4E506BFFE

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Nonspecific effect of Mycograb on amphotericin B MIC

@en

P2093

D L Richie

http://www.w3.org/2001/XMLSchema#string

K V Thompson

http://www.w3.org/2001/XMLSchema#string

M A Ghannoum

http://www.w3.org/2001/XMLSchema#string

N Isham

http://www.w3.org/2001/XMLSchema#string

N S Ryder

http://www.w3.org/2001/XMLSchema#string

P2860

Monoclonal antibody-based therapies for microbial diseases

Dose range evaluation of Mycograb C28Y variant, a human recombinant antibody fragment to heat shock protein 90, in combination with amphotericin B-desoxycholate for treatment of murine systemic candidiasis

Preclinical assessment of the efficacy of mycograb, a human recombinant antibody against fungal HSP90

Influence of human serum on antifungal pharmacodynamics with Candida albicans.

Effects of amphotericin B and fluconazole on the extracellular and intracellular growth of Candida albicans.

Evaluation of Mycograb, amphotericin B, caspofungin, and fluconazole in combination against Cryptococcus neoformans by checkerboard and time-kill methodologies.

A randomized, blinded, multicenter trial of lipid-associated amphotericin B alone versus in combination with an antibody-based inhibitor of heat shock protein 90 in patients with invasive candidiasis.

P304

3963-4

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.00435-12

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

56

http://www.w3.org/2001/XMLSchema#string

P577

2012-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22508314

http://www.w3.org/2001/XMLSchema#string

P921

infectious disease

P932

3393390

http://www.w3.org/2001/XMLSchema#string